Reported adverse events related to use of hepatitis C virus direct-acting antivirals with opioids: 2017 –2021

Due to concerns over potential interactions between some hepatitis C direct-acting antivirals (DAAs) and opioids, we describe adverse event (AE) reports of concomitant use of opioids and DAAs.

Source: Harm Reduction Journal - October 1, 2023 Category: Drugs & Pharmacology Authors: Anthony Martinez, Tipu Khan, Douglas E. Dylla, John Marcinak, Michelle Collins, Brad Saget and Brian Conway Tags: Brief Report Source Type: research